Tiziana Life Sciences ticks up on IND submission for mid-stage trial of its ALS treatment
Tiziana Life Sciences (NASDAQ:TLSA) rises after the company said it is planning the submission of its Investigational New ...
Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.
Tiziana Life Sciences Ltd.: Tiziana Life Sciences Files Investigational New Drug Application with FDA for ALS Phase 2 Clinical Trial
NEW YORK, March 04, 2025) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully hu ...
Tiziana Life Sciences files IND application with FDA for ALS Phase 2 trial
Tiziana Life Sciences (TLSA) announced the submission of its Investigational New Drug, IND, application to the U.S. Food and Drug ...
NHS says little-known mouth symptom could indicate Motor Neurone Disease
Experts warn that excessive saliva, or drooling, could be a potential indicator of motor neurone disease (MND), a condition ...
NHS warns mouth symptom could be life-shortening disease
The experts say if you notice that you produce a "lot of saliva (drool)", then this could indicate motor neurone disease (MND ...
studyfinds22h
Breakthrough blood test could transform ALS diagnosis, care
Find out about the new ALS blood test that offers accurate diagnosis and could replace traditional invasive testing methods.